A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope

AI Briefing

• – FDA faces crisis over lack of treatment options for certain diseases
• – New research offers hope for patients with rare conditions
• – Decades-old FDA regulations are being re-examined